Altria bought NJOY and plugged the company's vaping product into its distribution network. NJOY is enjoying a huge boost in sales, leading to enthusiasm among investors. There are good things ...

Recent marketing authorisation by the FDA for its NJOY vaping products gives hope that Altria might finally be able to transition to tobacco alternatives, where its lagging behind peers now. However, ...

Altria is reportedly in "advanced talks" to acquire #3 U.S. e-cigarette maker NJOY for $2.75bn. We see this as the wrong decision. NJOY is a distant #3 in U.S. Vapor. Precedents elsewhere suggest it ...

The company also resubmitted applications for its blueberry and watermelon-flavored pods. "Altria's vision is to responsibly lead the transition of adult smokers to a smoke-free future. We're excited ...

E-cigarette maker NJOY Holdings Inc. is pursuing a funding round that would value the company at as much as $5 billion, and it is trying to interest big tobacco companies looking to take a run at ...

The recent bankruptcy filing by e-cigarette maker NJoy might bode ill for the vaping industry. Scottsdale-based NJoy filed for Chapter 11 reorganization last week, announcing it was $32 million in ...

Income-oriented investors tend to be attracted to Altria Group (NYSE: MO) due to its high yield of 8.6% and long history of increasing its dividend every year since 2009. However, revenue growth has ...

Adult smokers are looking for alternatives and NJOY offers a multitude of products across three e-vapor categories. Officials at NJOY have a pretty specific mission: to make traditional cigarettes ...

The Food and Drug Administration’s first-ever authorization of menthol-flavored electronic cigarette devices may be a game-changer for public health for smokers trying to quit traditional cigarettes, ...

The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth. The stock is inexpensive with a robust dividend that is ...